跳至主要内容
临床试验/IRCT20200823048491N1
IRCT20200823048491N1已完成3 期

Evaluation of the effect of N-acetylcysteine ??(NAC) in cardio-pulmonary pump device in preventing kidney failure in coronary heart surgery

Esfahan University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 65 years(—)
性别
All

入选标准

  • Age 40 to 65 years
  • GFR greater than 60
  • Creatinine less than 1.5
  • Having conscious satisfaction
  • Patients with no previous history of open heart surgery
  • Patients undergoing CABG coronary artery bypass graft surgery
  • Patients who did not use ECMO and pump balloons before open heart surgery

排除标准

  • Patients undergoing CABG without Cardiopulmonary pump (CPB)
  • Patients who had valve surgery in addition to CABG surgery
  • Patients who are candidates for emergency CABG

研究者

相似试验

The effect of N-acetylcysteine ??(NAC) on renal... | 临床试验